trending Market Intelligence /marketintelligence/en/news-insights/trending/tOveKR8ZqZ8_kYWu48kqFQ2 content esgSubNav
Log in to other products

 /


Looking for more?

Contact Us
In This List

Calmare: US appeals court denies GEOMC's petition to reconsider March decision

Blog

COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021

Video

Climate Credit Analytics: Linking climate scenarios to financial impacts

Blog

Global M&A Infographic Q1 2021

Blog

Q1 2021 Global Capital Markets Activity: SPAC IPOs, Issuance in Consumer Discretionary Sector Surge


Calmare: US appeals court denies GEOMC's petition to reconsider March decision

Medical device manufacturer Calmare Therapeutics Inc. said the U.S. Court of Appeals for the 2nd Circuit denied GEOMC Co. Ltd.'s application to reconsider a March 2019 judgment.

The appeals court had overturned a 2017 judgment handed by the U.S. District Court for the District of Connecticut which awarded $10.4 million in damages to GEOMC. The appeals court then remanded the case to the district court for further proceedings.

South Korea's GEOMC had sued Calmare in 2014 in the district court for allegedly failing to comply with the terms of a security agreement.

Under the agreement, GEOMC was expected to manufacture Fairfield, Conn.-based Calmare's pain therapy device in exchange for a security interest in the devices.